Asset Search

License Type

Rights Holder

Subtype

Asset Type

Display Sensitive Materials

Journal Article Title

Add filter

Search Results

Displaying all 5 assets.

/assets?dynamic_filters%5Barticle_title%5D=Factors+Associated+With+Complete+Remission+After+Rituximab+Therapy+for+Pemphigus&template=grid

- Identifier
- doi190055f1
- License Type
- Rights Managed
- Rights Holder
- JAMA
Description Time to Relapse After Achieving Complete Remission Off Therapy (CROT) Time to relapse after achieving first CROT (n = 72; median, 23.3 months). Vertical marks indicate censored patients.
Article Title: Factors Associated With Complete Remission After Rituximab Therapy for Pemphigus
Publication Title: JAMA Dermatology

Add to Cart
- Identifier
- 15512_1404_doi190055t2
- License Type
- Rights Managed
- Rights Holder
- JAMA
Description Regression Analysis of Rates of CROT After the First Cycle of Rituximab
Article Title: Factors Associated With Complete Remission After Rituximab Therapy for Pemphigus
Publication Title: JAMA Dermatology

Add to Cart
- Identifier
- 15512_doi190055t1
- License Type
- Rights Managed
- Rights Holder
- JAMA
Description Patient Characteristics at Time of First Cycle of Rituximab
Article Title: Factors Associated With Complete Remission After Rituximab Therapy for Pemphigus
Publication Title: JAMA Dermatology

Add to Cart
- Identifier
- 15512_doi190055t2
- License Type
- Rights Managed
- Rights Holder
- JAMA
Description Regression Analysis of Rates of CROT After the First Cycle of Rituximab
Article Title: Factors Associated With Complete Remission After Rituximab Therapy for Pemphigus
Publication Title: JAMA Dermatology

Add to Cart
- Identifier
- 15512_1404_doi190055t1
- License Type
- Rights Managed
- Rights Holder
- JAMA
Description Patient Characteristics at Time of First Cycle of Rituximab
Article Title: Factors Associated With Complete Remission After Rituximab Therapy for Pemphigus
Publication Title: JAMA Dermatology

Add to Cart

Displaying all 5 assets.